| Metric | Q3 FY26 | Q2 FY26 | Q3 FY25 |
|---|---|---|---|
| Other income | 0.5 | 0.0 | 1.1 |
| Total income | 1.1 | 0.7 | 1.9 |
| Net profit | 0.2 | 0.0 | 1.2 |
| Operating margin | 27.3% | -14.3% | 57.9% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | -83.30% |
|---|
BSE results filing, NSE: GOLDENPROP. Figures extracted from the filing.
Garbi Finvest Ltd: key numbers
- Share price
- ₹8.97
- Market cap
- ₹10.52 Cr
- Revenue (annual)
- ₹2.55 Cr
- Net profit (annual)
- ₹-3.58 Cr
- P/E (TTM)
- -1.9×Sector 21.7×
- Promoter holding
- 59.28%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Garbi Finvest Ltd
All →Garbi Finvest Other Announcement
Garbi Finvest Limited has announced the closure of its register of members and share transfer register from 23rd September 2026 to 29th September 2026.
Garbi Finvest Annual Report
Garbi Finvest Limited has submitted its Annual Report for the financial year 2025-26. The 44th Annual General Meeting is scheduled for September 29, 2026.
Garbi Finvest Annual General Meeting
Garbi Finvest Ltd has issued a notice for its Annual General Meeting to be held on September 29, 2026. The meeting will consider financial statement adoption.
Garbi Finvest Q1 FY27 Results: Net Loss of ₹0.8 Cr
Garbi Finvest Ltd reported revenue from operations of ₹0.5 Cr (-16.7% YoY) and a net loss of ₹0.8 Cr for Q1 FY27.
- Key figure
- Net loss ₹0.8 Cr
Garbi Finvest Board Meeting Date
Garbi Finvest Ltd has scheduled a board meeting for August 13, 2026. The board will consider unaudited standalone financial results for the quarter ended June 2026.
Garbi Finvest Other Announcement
Garbi Finvest Limited submitted its Annual Secretarial Compliance Report for the financial year 2025-26. The report confirms adherence to SEBI regulations with no adverse observations or penalties.